These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 37884300)
1. Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q Deletion. Lasocki A; Buckland ME; Molinaro T; Xie J; Gaillard F AJNR Am J Neuroradiol; 2023 Nov; 44(11):1270-1274. PubMed ID: 37884300 [TBL] [Abstract][Full Text] [Related]
2. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas. Yang X; Lin Y; Xing Z; She D; Su Y; Cao D Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488 [TBL] [Abstract][Full Text] [Related]
3. MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement. Kang KM; Song J; Choi Y; Park C; Park JE; Kim HS; Park SH; Park CK; Choi SH Radiology; 2024 May; 311(2):e233120. PubMed ID: 38713025 [TBL] [Abstract][Full Text] [Related]
5. Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study. Habiba U; Sugino H; Yordanova R; Ise K; Tanei ZI; Ishida Y; Tanikawa S; Terasaka S; Sato KI; Kamoshima Y; Katoh M; Nagane M; Shibahara J; Tsuda M; Tanaka S Acta Neuropathol Commun; 2021 May; 9(1):95. PubMed ID: 34020723 [TBL] [Abstract][Full Text] [Related]
6. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance. Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548 [TBL] [Abstract][Full Text] [Related]
7. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in Batchala PP; Muttikkal TJE; Donahue JH; Patrie JT; Schiff D; Fadul CE; Mrachek EK; Lopes MB; Jain R; Patel SH AJNR Am J Neuroradiol; 2019 Mar; 40(3):426-432. PubMed ID: 30705071 [TBL] [Abstract][Full Text] [Related]
8. HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma. Felix M; Friedel D; Jayavelu AK; Filipski K; Reinhardt A; Warnken U; Stichel D; Schrimpf D; Korshunov A; Wang Y; Kessler T; Etminan N; Unterberg A; Herold-Mende C; Heikaus L; Sahm F; Wick W; Harter PN; von Deimling A; Reuss DE Neuro Oncol; 2022 Dec; 24(12):2121-2132. PubMed ID: 35511748 [TBL] [Abstract][Full Text] [Related]
9. The Histopathologic and Radiologic Features of T2-FLAIR Mismatch Sign in IDH-Mutant 1p/19q Non-codeleted Astrocytomas. Fujita Y; Nagashima H; Tanaka K; Hashiguchi M; Hirose T; Itoh T; Sasayama T World Neurosurg; 2021 May; 149():e253-e260. PubMed ID: 33610870 [TBL] [Abstract][Full Text] [Related]
10. Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted. Kikuchi K; Togao O; Yamashita K; Momosaka D; Kikuchi Y; Kuga D; Yuhei S; Fujioka Y; Narutomi F; Obara M; Yoshimoto K; Ishigami K Neuroradiology; 2024 Mar; 66(3):333-341. PubMed ID: 38224343 [TBL] [Abstract][Full Text] [Related]
11. Zhao K; Yu P; Xue Z; Liu J; Yao A; Zhao Y; Yang F; Tian J; Xu B Acad Radiol; 2020 Jul; 27(7):e159-e167. PubMed ID: 31607471 [TBL] [Abstract][Full Text] [Related]
13. Prediction of Park YW; Han K; Ahn SS; Bae S; Choi YS; Chang JH; Kim SH; Kang SG; Lee SK AJNR Am J Neuroradiol; 2018 Jan; 39(1):37-42. PubMed ID: 29122763 [TBL] [Abstract][Full Text] [Related]
15. MR textural analysis on T Rui W; Ren Y; Wang Y; Gao X; Xu X; Yao Z J Magn Reson Imaging; 2018 Jul; 48(1):74-83. PubMed ID: 29140606 [TBL] [Abstract][Full Text] [Related]
16. MRI Features Can Predict 1p/19q Status in Intracranial Gliomas. Lasocki A; Gaillard F; Gorelik A; Gonzales M AJNR Am J Neuroradiol; 2018 Apr; 39(4):687-692. PubMed ID: 29519793 [TBL] [Abstract][Full Text] [Related]
17. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign. Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467 [TBL] [Abstract][Full Text] [Related]
18. Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI. Johnson DR; Diehn FE; Giannini C; Jenkins RB; Jenkins SM; Parney IF; Kaufmann TJ AJNR Am J Neuroradiol; 2017 Apr; 38(4):678-684. PubMed ID: 28126746 [TBL] [Abstract][Full Text] [Related]
19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
20. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion. Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]